| __timestamp | Lantheus Holdings, Inc. | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 176081000 | 12665000 |
| Thursday, January 1, 2015 | 157939000 | 20202000 |
| Friday, January 1, 2016 | 164073000 | 32407000 |
| Sunday, January 1, 2017 | 169243000 | 35219000 |
| Monday, January 1, 2018 | 168489000 | 36386000 |
| Tuesday, January 1, 2019 | 172526000 | 43081000 |
| Wednesday, January 1, 2020 | 200649000 | 39330000 |
| Friday, January 1, 2021 | 237513000 | 43283000 |
| Saturday, January 1, 2022 | 353358000 | 48316000 |
| Sunday, January 1, 2023 | 586886000 | 54634000 |
Data in motion
In the competitive landscape of healthcare, cost efficiency is paramount. This analysis delves into the cost of revenue trends for Lantheus Holdings, Inc. and MiMedx Group, Inc. from 2014 to 2023. Over this period, Lantheus Holdings has demonstrated a remarkable increase in cost efficiency, with its cost of revenue surging by over 230%, from approximately $176 million in 2014 to nearly $587 million in 2023. In contrast, MiMedx Group's cost of revenue grew by about 330%, from $12.7 million to $54.6 million. Despite MiMedx's higher growth rate, Lantheus's larger scale and consistent growth highlight its robust market position. This data underscores the dynamic shifts in the healthcare sector, where strategic cost management can significantly impact a company's financial health and competitive edge.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Lantheus Holdings, Inc.
Cost of Revenue: Key Insights for AbbVie Inc. and Lantheus Holdings, Inc.
Viatris Inc. vs MiMedx Group, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc.
Comparing Cost of Revenue Efficiency: Halozyme Therapeutics, Inc. vs MiMedx Group, Inc.
Cost of Revenue Comparison: Pharming Group N.V. vs Lantheus Holdings, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Grifols, S.A.
Analyzing Cost of Revenue: Pharming Group N.V. and MiMedx Group, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Geron Corporation
Comparing Cost of Revenue Efficiency: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc.
Cost of Revenue Comparison: Cytokinetics, Incorporated vs MiMedx Group, Inc.